The incidence of three childhood neuropsychiatric disorders, including autism, increased among Danish children between 1990 and 2004, according to a report in the February issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
This disconnect between the scientific community and the popular media is starkly laid out in a study published in the February issue of Nature Reviews Neuroscience by researchers at the Stanford University School of Medicine.
Risperidone, a drug used to control schizophrenia symptoms, may also help treat behaviors found in autism spectrum disorder, according to a new review of studies.
A gene called SHANK3 is mutated in a small number of individuals with autism, providing new insight into the biological basis of this disease, according to a study to be published in the January issue of Nature Genetics.
Preliminary new research discussed today at the American College of Neuropsychopharmacology’s Annual Meeting finds that oxytocin, when administered using intravenous fluid and nasal technology may have significant positive effects on adult autism patients.
The 2006 American College of Neuropsychopharmacology annual meeting will feature hundreds of new studies on brain and behavior from the world’s leading scientists. Presentations include innovative research on potential new treatments for Alzheimer’s disease, autism, nicotine addiction and treatment resistant depression.
Exposure to industrial chemicals in the womb or early in life can impair brain development but only a handful are controlled to protect children, researchers said on Wednesday.
UT Southwestern Medical Center will host the North Texas Autism Summit, featuring presentations by national and local experts in autism research and treatment on Saturday, Nov. 11.
A child?s susceptibility to autism is increased with a single gene mutation according to research conducted by, a Vanderbilt-led research team. This discovery has far-reaching implications because this gene, a variant form of a gene called MET, is not just specifically a brain gene but rather a gene which has its effect on multiple systems in the body such as immune function and gut repair.
The U.S. Food and Drug Administration (FDA) approved a new use of one of the leading prescription antipsychotic medications, RISPERDAL(R) (risperidone), for the treatment of irritability associated with autistic disorder, including symptoms of aggression, deliberate self-injury, temper tantrums, and quickly changing moods, in children and adolescents aged 5 to 16 years.(1) This is the first time the FDA has approved any medication for use in children and adolescents with autism.